Reveleer Launches Next Generation Risk Solution for Unparalleled Accuracy, Efficiency, and Financial Performance

New AI-driven technology transforms retrospective risk adjustment with real-time insights enhancing coding precision and automated workflows

GLENDALE, Calif., March 5, 2025 /PRNewswire/ -- Reveleer, the leading value-based care enablement platform, today announced the launch of its next generation retrospective risk technology, designed to advance risk adjustment programs with unparalleled accuracy, efficiency, and compliance.

As payers and providers navigate increasingly complex regulatory environments, accurate risk adjustment has never been more critical. Reveleer's advanced technology ensures precise Medical Record Review (MRR) while improving operational and financial impact without compromising compliance. By harnessing the power of AI with EVE (Reveleer's Evidence Validation Engine), Reveleer now leads the market through its predictive clinical insights with up to 99% accuracy, advanced dynamic clinical validation, and intelligent automation that reduces coding duration by up to 42.5%. Combined with a modern user experience, Reveleer is transforming retrospective risk with remarkable accuracy, productivity and financial performance for its customers.

"Our platform is built for those seeking to modernize their risk adjustment programs with artificial intelligence assisted workflows," said Paul Burke, Chief Product Officer at Reveleer. "By leveraging our proprietary technology and intelligent automation, we provide our customers with the opportunity to increase their efficiency and productivity while improving their RAF accuracy and HCC capture."

Key benefits of Reveleer's AI-powered next-generation retrospective risk technology:

• AI-Powered clinical review: Clinical insights with up to 99% accuracy, minimizing coding errors and improving RAF capture.
• Dynamic HCC validation: Real-time hierarchical dynamic validation improves efficiency without compromising compliance or increasing audit risk.
• Seamless collaboration tools: Real-time audit log, annotations, and in-app messaging improve workflow efficiency and coordination.
• Enhanced member view: Comprehensive health profiles enable better clinical insights and accurate coding decisions.
• Optimized user experience: Dual-screen support, bulk actions, and dark mode enhance productivity and ease the cognitive burden for users.
• Powerful Platform: In 2024, we processed 1.1 billion pages of medical charts, and delivered 2.5 million diagnoses.

"Retrospective risk adjustment is critical for financial sustainability in value-based care, yet current technologies and manual processes are fragmented, time-consuming and prone to errors," said Jay Ackerman, CEO of Reveleer. "Our next generation risk solution is just the beginning of how Reveleer intends to lead the market into the next evolution of value-based care. The pressure of a changing value-based care ecosystem on our customers is only increasing, and so must our investment in innovation."

Reveleer will be exhibiting at RISE National, March 11 – 13, 2025 in San Antonio, TX where it will be showcasing this next generation risk solution, along with its quality and clinical intelligence solutions.

To learn more about Reveleer, our platform, and solutions, visit www.reveleer.com.

About Reveleer
As the industry's pioneering value-based care (VBC) enablement platform, Reveleer is purpose-built to solve the most pressing real-world challenges faced by providers and health-plan organizations today. By unifying retrieval, clinical intelligence, risk adjustment, quality improvement, and member management solutions into one intelligent, AI-powered system, Reveleer streamlines fragmented workflows to supercharge productivity, enhance care quality, and optimize performance on high-priority value-based initiatives. To learn more about Reveleer's value-based care platform, visit us at Reveleer.com.

SOURCE Reveleer